The Japanese experience with vaccinating schoolchildren against influenza

New England Journal of Medicine

Volumn 344, Issue 12, 2001, Pages 889-896

  Reichert, Thomas A ^a,g   Sugaya, Norio ^b   Fedson, David S ^c   Glezen, W Paul ^d   Simonsen, Lone ^e   Tashiro, Masato ^f  

^a Becton Dickinson and Entropy Limited   (United States)

^b NIPPON KOKAN HOSPITAL   (Japan)

^c SANOFI PASTEUR   (France)

^d BAYLOR COLLEGE OF MEDICINE   (United States)

^e NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^f NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^g NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE;

ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; HEALTH CARE POLICY; HUMAN; IMMUNITY; INFLUENZA; INFLUENZA VACCINATION; JAPAN; MAJOR CLINICAL STUDY; MORTALITY; PNEUMONIA; PRIORITY JOURNAL; SCHOOL CHILD; STATISTICAL ANALYSIS; VACCINATION;

EID: 0035932528     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM200103223441204     Document Type: Article

References (43)

1. Mortality and influenza
2. Serious morbidity and mortality associated with influenza epidemics
3. Impact of influenza epidemics on mortality in the United States from October 1972 to May 1985
4. The impact of influenza epidemics on mortality: Introducing a severity index
5. Pandemic versus epidemic influenza mortality: A pattern of changing age distribution
6. Clinical effectiveness of influenza vaccination in Manitoba
7. The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community
8. Benefits of influenza vaccination for low-, intermediate-, and high-risk senior citizens
9. The efficacy of influenza vaccine in elderly persons: A meta-analysis and review of the literature
10. Influenza vaccination in 22 developed countries: An update to 1995
11. Influenza vaccination in 29 countries: An update to 1997
12. Influenza immunization policies and practices in Japan
13. History of Asian influenza, the records of A2 influenza pandemic (1957-1958)
14. Japan lagging in influenza jabs
15. Experiences with mass vaccination of young age groups with inactivated vaccines
16. Questionnaire on effectiveness of immunization among Tokyo Pediatricians Society
17. Influenza vaccination for children and adults in Japan
18. Scepticism about influenza vaccine efficacy in Japan
19. The epidemiological basis for the control of influenza
20. Modification of an outbreak of influenza in Tecumseh, Michigan, by vaccination of schoolchildren
21. An influenza simulation model for immunization studies
22. An optimization model for influenza A epidemics
23. Statistical inference for infectious diseases: Risk-specific household and community transmission parameters
24. A field trial for evaluation of the prophylactic effect of influenza vaccine containing inactivated A2-Hong Kong and B influenza viruses
25. Various factors associated with the manifestation of influenza-like illness
26. Efficacy of inactivated vaccine in preventing antigenically drifted influenza type A and well-matched type B
27. Advance report of final mortality statistics, 1993-1998
28. An evaluation of influenza mortality surveillance 1962-1979. II. Percentage of pneumonia and influenza deaths as an indicator of influenza activity
29. Protecting Japan from influenza
30. The health and economic benefits of influenza vaccination for healthy and at-risk persons aged 65 to 74 years
31. The effect of influenza on hospitalizations, outpatient visits, and courses of antibiotics in children
32. Influenza and the rates of hospitalization for respiratory disease among infants and young children
33. The impact of winter epidemics of influenza and respiratory syncytial virus on paediatric admissions to an urban general hospital
34. The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children
35. Efficacy of vaccination with live attenuated, cold-adapted, trivalent intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine
36. Estimation of the efficacy of live, attenuated influenza vaccine from a two-year, multi-center vaccine trial: Implications for influenza epidemic control
37. Potential cost savings attributable to influenza vaccination of school-aged children
38. Influenza vaccine